Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma

Autor: Colafrancesco V., Parisi V., Sposato V., Rossi S., Russo M.A., Coassin M., Lambiase A., Aloe L.

Publikováno v: Journal of glaucoma 20(2) (2011): 100–108.
info:cnr-pdr/source/autori:Colafrancesco V., Parisi V., Sposato V., Rossi S., Russo M.A., Coassin M., Lambiase A., Aloe L./titolo:Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma/doi:/rivista:Journal of glaucoma/anno:2011/pagina_da:100/pagina_a:108/intervallo_pagine:100–108/volume:20(2)
Journal of glaucoma 20(2) (2010): 100–108.
info:cnr-pdr/source/autori:Colafrancesco V., Parisi V., Sposato V., Rossi S., Russo M.A., Coassin M., Lambiase A., Aloe L./titolo:Ocular Application of Nerve Growth Factor Protects Degenerating Retinal Ganglion Cells in a Rat Model of Glaucoma/doi:/rivista:Journal of glaucoma/anno:2010/pagina_da:100/pagina_a:108/intervallo_pagine:100–108/volume:20(2)

PURPOSE: Elevated intraocular pressure is a crucial pathologic event for the development of glaucoma (GL). We have reported that nerve growth factor (NGF) reaches retinal cells and the optic nerve (ON) when applied to the eye. Whether ocular applicat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::628d183caf99b9a5c1a38b4b9c49e746
http://www.cnr.it/prodotto/i/59277

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

Autor: Lambiase A. a), Aloe L. b), Centofanti M. c), Parisi V. d), Mantelli F. a), Colafrancesco V. d), Manni G.L. c), Bucci M.G. c), Bonini S. a), Levi-Montalcini R. e)

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America 106 (2009): 13469–13474.
info:cnr-pdr/source/autori:Lambiase A. a), Aloe L. b), Centofanti M. c),d), Parisi V. d), Mantelli F. a), Colafrancesco V. d), Manni G.L. c), d), Bucci M.G. c), d), Bonini S. a), Levi-Montalcini R. e)/titolo:Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma/doi:/rivista:Proceedings of the National Academy of Sciences of the United States of America/anno:2009/pagina_da:13469/pagina_a:13474/intervallo_pagine:13469–13474/volume:106

Elevated intraocular pressure (IOP) in glaucoma causes loss of retinal ganglion cells (RGCs) and damage to the optic nerve. Although IOP is controlled pharmacologically, no treatment is available to restore retinal and optic nerve function. We evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::706bc0a9272fc2b80c18429b2bdead8b
http://www.cnr.it/prodotto/i/4892

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

We-P11:16 Diabetes mellitus have immune system alterations similar to that of unstable angina: A clue to explain high cardiovascular risk of diabetes

Autor: Brugaletta, S., Giubilato, S., Pitocco, D., Narducci, M., Colafrancesco, V., Ghirlanda, G., Biasucci, L., Liuzzo, G., Conte, M., Crea, F.

Publikováno v: In Atherosclerosis (Supplements) (Component) 2006 7(3):349-349

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.